Does Rallies show IBRN price targets?

Yes. Rallies tracks IBRN analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is IBRN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IBRN. It does not provide personalized investment advice.

IBRN (iShares Neuroscience and Healthcare ETF) Stock Analysis - Analyst Ratings

iShares Neuroscience and Healthcare ETF (IBRN) is a publicly traded the market company. As of May 21, 2026, IBRN trades at $28.16 with a market cap of $0 and a P/E ratio of 0.00. IBRN moved +0.89% today. Year to date, IBRN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate IBRN?

The average price target is $0.00.

IBRN Key Metrics

Key financial metrics for IBRN
Metric	Value
Price	$28.16
Market Cap	$0
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$0.00
52-Week Low	$0.00
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

IBRN Analyst Consensus

IBRN analyst coverage data. Average price target: $0.00.

Common questions about IBRN

What do analysts rate IBRN?: The average price target is $0.00.
Does Rallies show IBRN price targets?: Yes. Rallies tracks IBRN analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is IBRN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IBRN. It does not provide personalized investment advice.